Openness in research and development: co-patenting impact on breakthrough innovations in the pharmaceutical industry
by Alfred Osta; Bassem Maamari
International Journal of Business Innovation and Research (IJBIR), Vol. 21, No. 3, 2020

Abstract: Breakthrough innovations are crucial drivers of economic progress, often depending on external knowledge sources to complement internal knowledge. Co-patenting is one way to achieve this by implementing open innovation within research and development. The purpose of this paper is to explore the impact of co-patenting on breakthrough innovations in the pharmaceutical industry. A research question is tested empirically using an archival dataset comprising 866 patents in Pharma. The findings show that co-patenting has a significant positive impact on breakthrough innovations. Short of previous investigation, this paper provides new empirical insights on the open innovation and co-patenting levels, leading to both academic and practical implications on the field.

Online publication date: Wed, 18-Mar-2020

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Business Innovation and Research (IJBIR):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com